Patent Assignment
Reel/Frame 049108/0698
Change of Name
Recorded: 2019-04-02
Pages: 2
Assignor
CELLADON CORPORATION
Executed: 2016-03-22
Assignee
EIGER BIOPHARMACEUTICALS, INC.
12760 HIGH BLUFF DRIVE, SUITE 240, SAN DIEGO, CALIFORNIA, 92130
Covered Property
(1)
Fluorescence Resonance Energy Transfer Assays for Sarco/Endoplasmic Reticulum Calcium Atpase and Phospholamban
Related Assignments
(7)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 24, 2012
From: ZSEBO, KRISZTINA M.
To: CELLADON CORPORATION
Reel/Frame 027587/0450 →
Assignment of Assignor's Interest
Jan 24, 2012
From: THOMAS, DAVID D.; CORNEA, RAZVAN L.
To: REGENTS OF THE UNIVERSITY OF MINNESOTA
Reel/Frame 027587/0341 →
Confirmatory License
Nov 5, 2012
From: REGENTS OF THE UNIVERSITY OF MINNESOTA
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029244/0490 →
Merger
Apr 2, 2019
From: CELLADON CORPORTION, A CALIFORNIA CORPORATION
To: CELLADON CORPORATION, A DELAWARE CORPORATION
Reel/Frame 048767/0852 →
Assignment of Assignor's Interest
Apr 10, 2019
From: EIGER BIOPHARMACEUTICALS, INC.
To: THERAGENE PHARMACEUTICALS, INC.
Reel/Frame 048847/0256 →
Abstract of Judgment
Aug 18, 2020
From: ZSEBO, KRISZTINA
To: THERAGENE PHARMACEUTICALS, INC.
Reel/Frame 053529/0133 →
Lien
Aug 19, 2020
From: THERAGENE PHARMACEUTICALS, INC.
To: ZSEBO, KRISZTINA
Reel/Frame 053555/0715 →